UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q2 2022 | 2021-10-27 | Future report Set alerts | |
| Q1 2022 | 2021-08-05 | Future report Set alerts | |
| Q4 2021 | 2021-04-29 | 1.24 | 1.24 |
| Q3 2021 | 2021-01-28 | 1.35 | 1.35 |
| Q2 2021 | 2020-10-29 | 1.36 | 1.36 |
| Q1 2021 | 2020-08-06 | 0.98 | 0.98 |
| Q4 2020 | 2020-04-30 | 0.70 | 0.70 |
| Q3 2020 | 2020-02-06 | 1.51 | 1.51 |
| Q2 2020 | 2019-10-31 | 0.28 | 0.28 |
| Q2 2019 | 2019-08-03 | 2.50 | 5.74 |
| 2016-06-10 | Reiterated Rating | Jefferies Group | Buy | $125.00 |
| 2016-05-05 | Reiterated Rating | Leerink Swann | Buy | |
| 2016-05-04 | Boost Price Target | Leerink Swann | Outperform | $120.00 to $125.00 |
| 2016-04-17 | Reiterated Rating | Leerink Swann | Buy | |
| 2016-04-10 | Reiterated Rating | Benchmark Co. | Buy | $145.00 |
| 2016-04-09 | Reiterated Rating | Jefferies Group | Buy | |
| 2016-04-08 | Reiterated Rating | Leerink Swann | Buy | |
| 2016-03-22 | Reiterated Rating | Jefferies Group | Buy | $125.00 |
| 2016-02-05 | Reiterated Rating | Piper Jaffray | Hold | $75.00 to $90.00 |
| 2016-02-05 | Reiterated Rating | BTIG Research | Buy | $110.00 |
| 2016-02-05 | Reiterated Rating | Piper Jaffray Cos. | Hold | $75.00 to $90.00 |
| 2016-02-04 | Boost Price Target | Benchmark Co. | Buy | $133.00 to $145.00 |
| 2015-10-30 | Upgrade | Raymond James | Market Perform to Outperform | $85.00 |
| 2015-10-30 | Reiterated Rating | Leerink Swann | Outperform | $115.00 to $95.00 |
| 2015-10-30 | Boost Price Target | Benchmark Co. | $129.00 to $133.00 | |
| 2015-10-30 | Upgrade | Raymond James Financial Inc. | Market Perform to Outperform | $85.00 |
| 2015-10-29 | Reiterated Rating | BTIG Research | Hold | |
| 2015-10-29 | Reiterated Rating | Sterne Agee CRT | Buy | |
| 2015-10-15 | Reiterated Rating | BTIG Research | Hold | |
| 2015-09-23 | Reiterated Rating | BTIG Research | Neutral | |
| 2015-08-18 | Initiated Coverage | Sterne Agee CRT | Buy | $130.00 |
| 2015-08-17 | Initiated Coverage | CRT Capital | Buy | |
| 2015-08-14 | Reiterated Rating | Stephens | Overweight | $103.00 to $128.00 |
| 2015-08-12 | Reiterated Rating | BTIG Research | Hold | |
| 2015-08-12 | Reiterated Rating | Jefferies Group | Buy | $125.00 |
| 2015-08-12 | Boost Price Target | Benchmark Co. | Buy | $96.00 to $129.00 |
| 2015-08-05 | Reiterated Rating | Piper Jaffray | Hold | $71.00 to $85.00 |
| 2015-08-05 | Boost Price Target | Northland Securities | Market Perform | $60.00 to $80.00 |
| 2015-08-04 | Reiterated Rating | BTIG Research | Hold | |
| 2015-08-04 | Boost Price Target | Benchmark Co. | Buy | $89.00 to $96.00 |
| 2015-05-09 | Reiterated Rating | Jefferies Group | Buy | $72.00 to $83.00 |
| 2015-05-06 | Reiterated Rating | BTIG Research | Neutral | |
| 2015-05-06 | Boost Price Target | Leerink Swann | Outperform | $72.00 to $88.00 |
| 2015-05-06 | Boost Price Target | Northland Securities | Market Perform | $40.00 to $60.00 |
| 2015-03-24 | Reiterated Rating | BTIG Research | Positive | |
| 2015-02-17 | Boost Price Target | Leerink Swann | Outperform | $60.00 to $72.00 |
| 2015-01-29 | Reiterated Rating | BTIG Research | Neutral | |
| 2015-01-29 | Boost Price Target | Leerink Swann | Outperform | $43.00 to $60.00 |
| 2015-01-28 | Upgrade | Northland Securities | Under Perform to Market Perform | |
| 2015-01-28 | Reiterated Rating | Jefferies Group | Buy | $45.00 to $56.00 |
| 2015-01-05 | Reiterated Rating | Jefferies Group | Buy | $37.00 to $45.00 |
| 2014-11-03 | Downgrade | BTIG Research | Buy to Neutral | |
| 2014-03-24 | Initiated Coverage | Leerink Swann | Outperform | $34.00 |
| 2014-03-21 | Upgrade | BTIG Research | Neutral to Buy | |
| 2014-02-20 | Initiated Coverage | BTIG Research | Neutral | |
| 2014-01-10 | Boost Price Target | Wunderlich | Buy | $29.00 to $35.00 |
| 2013-11-10 | Reiterated Rating | Benchmark Co. | Buy | $25.00 |
| 2013-11-07 | Boost Price Target | Northland Securities | Underperform | $9.00 to $14.00 |
| 2013-11-07 | Boost Price Target | Jefferies Group | Buy | $25.00 to $30.00 |
| 2013-10-08 | Upgrade | The Benchmark Company | Speculative Buy to Buy | $25 |
| 2013-10-01 | Initiated | The Benchmark Company | Speculative Buy | $25 |
| 2013-10-01 | Initiated Coverage | Benchmark Co. | Speculative Buy to Buy | $25.00 |
| 2012-10-18 | Initiated | Northland Securities | Under Perform | $14 |
| 2012-05-17 | Reiterated | Wunderlich | Buy | $27 to $29 |
| 2011-12-19 | Downgrade | Rodman & Renshaw | Mkt Perform to Mkt Underperform | $13 |
| 2011-08-15 | Upgrade | Rodman & Renshaw | Mkt Underperform to Mkt Perform | |
| 2011-05-19 | Reiterated | Wunderlich | Buy | $18 to $24 |
| 2011-05-19 | Reiterated | Wedbush | Outperform | $16 to $22 |
| 2011-04-29 | Upgrade | Robert W. Baird | Neutral to Outperform | $16 to $20 |
| 2010-12-09 | Initiated | Wunderlich | Buy | $14 |
| 2010-12-08 | Downgrade | Rodman & Renshaw | Mkt Perform to Mkt Underperform | $6 |
| 2010-10-28 | Initiated | Robert W. Baird | Neutral | $12 |
| 2010-05-11 | Upgrade | Wedbush | Neutral to Outperform | $13 to $14 |
| 2010-01-08 | Initiated | Rodman & Renshaw | Mkt Perform | |
| 2009-10-30 | Downgrade | UBS | Neutral to Sell | |
| 2009-09-16 | Upgrade | Wedbush Morgan | Underperform to Neutral | $12 |
| 2009-04-09 | Initiated | Piper Jaffray | Buy | |
| 2009-03-25 | Upgrade | UBS | Neutral to Buy | |
| 2009-03-12 | Upgrade | Jefferies & Co | Underperform to Hold | $8 to $7 |
| 2016-06-10 | Reiterated Rating | Jefferies Group | Buy | $125.00 |
| 2016-05-05 | Reiterated Rating | Leerink Swann | Buy | |
| 2016-05-04 | Boost Price Target | Leerink Swann | Outperform | $120.00 to $125.00 |
| 2016-04-17 | Reiterated Rating | Leerink Swann | Buy | |
| 2016-04-10 | Reiterated Rating | Benchmark Co. | Buy | $145.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In ABMD 368 funds of 2199 total. Show all
| Fund name | Ticker shares |
|---|---|
| Vanguard Group, Inc | 4.81M |
| BlackRock Inc. | 4.14M |
| BAILLIE GIFFORD & CO | 3.44M |
| WELLINGTON MANAGEMENT CO LLP | 2.05M |
| PRIMECAP MANAGEMENT CO/CA/ | 1.92M |
| STATE STREET CORP | 1.90M |
| RENAISSANCE TECHNOLOGIES LLC | 1.78M |
| BlackRock Fund Advisors | 1.64M |
| BROWN CAPITAL MANAGEMENT LLC | 1.60M |
| BlackRock Institutional Trust Company, N.A. | 1.23M |
| CREDIT SUISSE AG/ | 0.91M |
| ALLIANCEBERNSTEIN L.P. | 0.84M |
| GEODE CAPITAL MANAGEMENT, LLC | 0.78M |
| Bank of New York Mellon Corp | 0.69M |
| AMERIPRISE FINANCIAL INC | 0.62M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| TERMEER HENRI A | 0.85% (345533) | ABMD / AGN / AVEO / VSTM / |
| SUTTER MARTIN P | 0.41% (166377) | ABMD / LJPC / |
| Weber David M Chief Operating Officer | 0.27% (108622) | ABMD / |
| AUSTEN W GERALD | 0.22% (87241) | ABMD / |
| Bowen Robert Chief Financial Officer | 0.19% (76265) | ABMD / |
| BOLT WILLIAM J SVP, QA and Regulatory Affairs | 0.16% (64748) | ABMD / |
| Howley Michael G VP, Global Sales & Marketing | 0.12% (46757) | ABMD / |
| Greenfield Andrew J VP Healthcare Solutions | 0.10% (42159) | ABMD / |
| MINOGUE MICHAEL R President, CEO, Chairman | 0.09% (38000) | ABMD / PODD / |
| LATAIF LOUIS E | 0.08% (34175) | ABMD / GPI / |
| PUHY DOROTHY E | 0.08% (33168) | ABMD / EV / |
| TOMSICEK MICHAEL JOHN Vice President, CFO | 0.07% (27081) | ABMD / CBST / |
| ROSE ERIC A MD | 0.03% (12652) | ABMD / SIGA / |
| THOMAS PAUL | 0.03% (12172) | ABMD / AEGR / ROKA / RTIX / |
| Van Gorder Chris | 0.02% (6415) | ABMD / |
| RIVET JEANNINE M | 0.02% (6415) | ABMD / |
| Trapp Todd A Vice President, CFO | 0.02% (6288) | ABMD / WTS / |
UM